Therapeutic Advances in Drug Safety
Overview
Therapeutic Advances in Drug Safety is a scientific journal, published by Sage Publications since 2010 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
Ther Adv Drug Saf
Publisher
Sage Publications
Start
2010
End
Continuing
Frequency
Bimonthly
p-ISSN
2042-0986
e-ISSN
2042-0994
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 7869
46
SJR / Ranks: 3587
1035
CiteScore / Ranks: 5372
4.80
JIF / Ranks: 1945
4.4
Recent Articles
1.
Xu J, Wang R, Shen K
Ther Adv Drug Saf
. 2025 Mar;
16:20420986251324633.
PMID: 40026915
Background: Although there are reports of adverse events (AEs) of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, the safety of ribociclib alone has not yet been comprehensively evaluated in real-world...
2.
Niazi S, Mariam Z
Ther Adv Drug Saf
. 2025 Feb;
16:20420986251321704.
PMID: 40008227
Artificial intelligence (AI) is transforming medication research and development, giving clinicians new treatment options. Over the past 30 years, machine learning, deep learning, and neural networks have revolutionized drug design,...
3.
Tseng Y, Tai C, Chen G, Chen Y, Ku S, Pai T, et al.
Ther Adv Drug Saf
. 2025 Feb;
16:20420986251320414.
PMID: 39974281
Background: Patients with low body weight (LBW) often exhibit altered pharmacokinetics (PK) in renal clearance and total body water. These changes complicate β-lactam antibiotic dosing, potentially resulting in suboptimal efficacy...
4.
Fu R, Chen J, Fang Y, Wu Q, Zhang X, Wang Z
Ther Adv Drug Saf
. 2025 Feb;
16:20420986251318842.
PMID: 39974280
Background: The association between dipeptidyl peptidase-4 inhibitors (DPP-4i) exposure and the risk of colorectal cancer (CRC) in patients with type 2 diabetes mellitus (T2DM) is unclear. Objectives: This meta-analysis aims...
5.
Bello W, Pezzatti J, Stampfli C, Carrez L, Rudaz S, Sadeghipour F
Ther Adv Drug Saf
. 2025 Feb;
16:20420986251317424.
PMID: 39958972
Hospital pharmacies play a unique role in healthcare by regularly compounding drug products (DPs) in response to hospital demands and practices, for example, drug shortages, to cater to frail and...
6.
Sangpornsuk N, Rungpradubvong V, Tiensantisuk T, Leelapattana P, Chokesuwattanakul R, Prechawat S
Ther Adv Drug Saf
. 2025 Feb;
16:20420986251316462.
PMID: 39944374
Background: Current guidelines recommend the use of only on a limited basis in patients with normal or minimal structural heart disease. The CAST study, the only randomized controlled trials, showed...
7.
Roncero C, Merizalde-Torres M, Szerman N, Torrens M, Vega P, Andres-Olivera P, et al.
Ther Adv Drug Saf
. 2025 Jan;
16:20420986241310685.
PMID: 39882342
In 2019, intranasal esketamine gained approval as a promising therapy for those individuals grappling with treatment-resistant depression. Both clinical trials and real-world studies have underscored its efficacy in alleviating and...
8.
Moran-Marinos C, Llanos-Tejada F, Huamani-Llantoy R, Bernal-Turpo C, Lopez-Pilco K, Ventura-Leon A, et al.
Ther Adv Drug Saf
. 2025 Jan;
16:20420986241312484.
PMID: 39866544
The overlap of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and Stevens-Johnson syndrome (SJS) caused by antituberculosis drugs represents an extremely rare event. This situation can manifest between 2...
9.
Contu S, Schiappa R, Chateau Y, Chamorey E
Ther Adv Drug Saf
. 2025 Jan;
16():20420986241299567.
PMID: 39830586
Background: Reporting serious adverse events (SAEs) is crucial to reduce or avoid toxicities that can lead to major consequences for patient's health due to treatments tested in clinical trials. Its...
10.
Schroder S, Massarou C, Pfister T, Bleich S, Proskynitopoulos P, Heck J, et al.
Ther Adv Drug Saf
. 2025 Jan;
16():20420986241311214.
PMID: 39830585
Background: The majority of patients with alcohol use disorder (AUD) regularly take medication. Alcohol interacts negatively with many commonly prescribed drugs. However, little is known about the characteristics and frequency...